ST. LOUIS, Sept. 28, 2011 /PRNewswire/ -- K-V Pharmaceutical Company (the "Company") (NYSE: KVa/KVb) today announced that Thomas McHugh, Chief Financial Officer, will present at Imperial Capital's 5th Annual Global Opportunities Conference on Thursday, October 6, 2011 at 10:55 a.m. EDT at the Grand Hyatt in New York. The presentation will be available via webcast. To access the webcast, please go to the investor relations portion of the Company's website at www.kvpharmaceutical.com and visit the "Upcoming Investor Events" tab. Please log-in at least 10 minutes prior to the start time to ensure a connection. The web cast of the presentation will be archived for thirty days. About K-V Pharmaceutical Company K-V Pharmaceutical Company is a specialty branded pharmaceutical company with a primary focus in the area of women's healthcare. As such, we are committed to advancing the health of women across all the stages of their lives. For further information about K-V Pharmaceutical Company, please visit the Company's corporate Website at www.kvpharmaceutical.com. SOURCE K-V Pharmaceutical Company
K-V Pharmaceutical Company (NYSE:KV.A) is trading at unusually high volume Friday with 3.6 million shares changing hands. It is currently at four times its average daily volume and trading down 93 cents (-35.6%).
K-V Pharmaceutical Company (NYSE:KV.A) is trading at unusually high volume Wednesday with 11.7 million shares changing hands. It is currently at 4.2 times its average daily volume and trading down $2.25 (-31.6%).